Gennex Laboratories Ltd.

GENNEX

₹13.82

-0.36% (-0.05)

Market Cap

₹314 Cr.

P/E

16.88

About

Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine.

Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediat… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Gennex Laboratories Ltd. Business

What does Gennex Lab do?

Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.

Who are the competitors of Gennex Lab?

Gennex Lab major competitors are Trident Lifeline, Fredun Pharma, Ambalal Sarabhai Ent, Balaxi Pharma., Coral Laboratories, Alpa Lab, Brooks Laboratories.
Market Cap of Gennex Lab is ₹315 Crs.
While the median market cap of its peers are ₹310 Crs.

Is Gennex Lab financially stable compared to its competitors?

Gennex Lab seems to be less financially stable compared to its competitors.
Altman Z score of Gennex Lab is 5.22 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Jun
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Gennex Laboratories Ltd.